This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The primary outcome measures were hospital length of stay (LOS), frequency of readmission (within 12 months), and time to first readmission. All measures were collected for the whole patient sample. The secondary outcome measures were community resource use post-discharge, patient satisfaction, diabetes knowledge, and disease-specific quality of life.
Community resource use post-discharge included outpatient attendance, contacts with primary and social care, and time away from normal activities. It was recorded at one month post-discharge by post.
Patient satisfaction was measured using a modified version of the Diabetes Clinic Satisfaction Questionnaire, which was administered one week post-discharge.
Diabetes knowledge was assessed using the Diabetes Knowledge Scale, which had been modified to provide a version for insulin users and non-users. It was administered at randomisation and at one week post-discharge by post.
Disease-specific quality of life was measured through the Audit of Diabetes Dependent Quality of Life (ADDQoL) instrument. It was assessed at randomisation and at one week post-discharge by post.
Data were obtained from questionnaires for 47% of the patients, while data on resource use post-discharge were available for 41% of the patients. The two study groups were comparable at baseline in terms of their age gender and specialty of admission. However, there was a greater proportion of patients with Type 1 diabetes in the intervention group. In addition, the patients who completed the questionnaire were significantly younger and less dependent on admission and discharge than those who did not complete the questionnaire. A comparison of non-participants and intervention group patients showed no differences in their age, gender or type of diabetes.
Effectiveness results
The median LOS was 8 days in the intervention group and 11 days in the control group, (p<0.01).
The readmission rate was 25% in both groups. The mean time to readmission was 283.2 days in the intervention group and 278 days in the control group, (p=0.80).
In the intervention group, 91% of the patients were satisfied with the care, 3% slightly dissatisfied and 3% dissatisfied, while in the control group, the proportions were 59% (satisfied), 23% (slightly dissatisfied) and 9% (dissatisfied), (p<0.001).
At baseline, the diabetes knowledge scores were 52% in the intervention group and 44% in the control group, (p>0.05). These increased to 74% in the intervention group and 48% in the control group. The difference in increase was statistically significant between the study groups.
The ADDQoL scores were 0.65 at baseline and 0.88 post-study for the intervention group, and 0.88 at baseline and 0.40 post-study for the control group, (p>0.05).
In terms of resource use following discharge, the mean number of contacts with a general practitioner (GP) was 1 in the intervention group and 1.7 in the control group, (p<0.01). Other contacts and time away from normal activities were similar in the intervention (4.9 and 11.3 days) and control (4 and 15.5 days) groups.
Overall, referrals to the community DSN service were 28.4% in the intervention group and 38.2% in the control group, (p=0.09).
Clinical conclusions
The effectiveness analysis showed that the DSN service proved to be a safe intervention, which improved patient satisfaction and significantly reduced the hospital LOS.
Measure of benefits used in the economic analysis
The health outcomes were left disaggregated and no summary benefit measure was used. A cost-consequences analysis was therefore carried out.
Direct costs
Discounting was irrelevant as the costs were incurred less than 2 years. The unit costs and the quantities of resources were not reported separately. The costs included in the analysis were inpatient hospitalisation costs and the cost per patient for the DSN service. The inpatient hospitalisation costs were estimated using specialty-specific fixed and marginal costs, which were derived from national cost data. The cost per patient for the DSN service was assessed by dividing the nurse's salary and overhead costs by the typical annual workload of a DSN. The cost/resource boundary appears to have been that of the hospital. The resources used were measured from January 1997 to September 1998. The costs were reported in 1997 to 1998 prices.
Statistical analysis of costs
Statistical analyses were carried out to test for statistical significance of the results. These were conducted on the total costs and the resource use, in terms of the hospital LOS, readmission rates, GP and other contacts, and referrals to the DSN service.
Indirect Costs
The indirect costs were not included in the analysis.
Currency

UK pounds sterling ().
Sensitivity analysis
Statistical analyses were performed to take into account the uncertainty of the cost data. The cost items varied were the salary costs, salary overheads, nurse workload, estimate of marginal costs, and LOS difference.
Estimated benefits used in the economic analysis
See the 'Effectiveness Results' section.
Cost results
The mean hospital costs amounted to 2,174 in the intervention group and 2,610 in the control group. There was a difference of -436 (bootstrapped 95% confidence interval: -1,125.2 to 206.3; p=0.19) in favour of the DSN service. The estimated costs were fairly robust and were only sensitive to quite unrealistic variations in the LOS and marginal costs.
